Czechia· CZ-0151885
NITRESAN
A nitrendipine product containing nitrendipine, registered in Czechia by PRO.MED.CS Praha a.s.. The same ATC class is registered in 6 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Nitrendipine is registered in 6 of 19 countries.
Countries holding a registration under ATC C08CA08 (nitrendipine), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Nitrendipine · ATC C08CA08
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Germany
- Polandprice
- Spainprice
Price per daily dose
What a daily dose of nitrendipine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nitrendipine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- FR France$0.37
- ES Spain$0.36
The record
At a glance
SÚKL (Czech Republic)- Active substance
- NITRENDIPINE
- Manufacturer
- PRO.MED.CS Praha a.s.
- Country
- Czechia (CZ)
- ATC code
- C08CA08
- ATC class
- Nitrendipine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for nitrendipine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nitrendipine · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Nitrendipine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandNitrendypina EgisEgis Pharmaceuticals PLC
- FranceNITRENDIPINE VIATRIS 10 mg, compriméVIATRIS SANTE
- GermanyNitrendipin AbzAbz-Pharma Gmbh
- BelgiumBaypress 20, 20 mgBayer
- SpainNITRENDIPINO STADA 20 mg COMPRIMIDOS EFGLaboratorio Stada S.L.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Germany · Nitrendipin Abz, Nitrendipin Al
- Estonia · Lusopress, Nitresan
- France · Nitrendipine Viatris
- Greece · Lisba, Nelconil
- Italy · Lusopress
- Lithuania · Lusopress, Nitresan
- Latvia · Lusopress, Nitresan
- Poland · Nitrendypina Egis, Nitresan
- Portugal · Hiperdipina
- Slovakia · Lusopress, Nitresan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e016453c-df7d-4b6c-80d6-fa92b5db3977 GET /v1/drugs/e016453c-df7d-4b6c-80d6-fa92b5db3977?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL NOB",
"source": "sukl",
"strength": "10MG",
"pack_size": "60",
"substance": "NITRENDIPINE",
"cz_kod_sukl": "0151885",
"product_type": "CH",
"substance_codes": "8668",
"registration_state": "R",
"registration_number": "58/667/07-C"
}See everything about nitrendipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.